SCHEMBL21076117

SCHEMBL21076117

CC(C)c1ccc(-n2c3cccc(-c4ccccc4)c3c3c(-c4ccccc4)cccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TP53 P04637 1/20 0.38
DHODH Q02127 1/20 0.37
FABP3 P05413 1/20 0.36
FABP4 P15090 1/20 0.36
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26481042 0.79 PDE6D (0.42) ALDH1A1HTTNPSR1KDM4EL3MBTL1
SCHEMBL21076084 0.78 DHODH (0.43) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL22148481 0.78 TP53 (0.39) SMN1; SMN2ALDH1A1NPC1RAB9ATP53
SCHEMBL19011028 0.78 KDM4E (0.41) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL24849164 0.76 L3MBTL1 (0.42) ALDH1A1MEN1KMT2AHTTTP53
SCHEMBL26415859 0.76 KDM4E (0.42) SMN1; SMN2DHODHKDM4EL3MBTL1ATM
SCHEMBL26254160 0.75 PDCD1 (0.40) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL16997217 0.75 ADORA3 (0.40) ALDH1A1MEN1KMT2ANPC1HTT
SCHEMBL1102414 0.74 KDM4E (0.59) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL22137016 0.74 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190173020-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 US disclosed
US-20190173019-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 US disclosed
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190173019-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA SMN1; SMN2 1804/4885ALDH1A1 60/4885MEN1 2756/4885
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA SMN1; SMN2 1804/4885ALDH1A1 60/4885MEN1 2756/4885
US-20190173020-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA SMN1; SMN2 1804/4885ALDH1A1 60/4885MEN1 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.